Stay updated on Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Version 3.5.2 adds comprehensive study data sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, IPDSharing, Eligibility, Arms and Interventions, Study Design, Study Description, Study Status, Study Identification, Recruitment Status). It updates the revision timeline to reflect the new changes (Revision: v3.5.2, dated 2026-03-25).
    Difference
    2%
    Check dated 2026-04-16T11:09:32.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The history now shows 'Results Submitted' replacing 'No Results Posted'. The entry updates the record to indicate that study results have been submitted.
    Difference
    0.1%
    Check dated 2026-04-02T01:33:25.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the prior v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:14:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:12:59.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and earlier items including a government funding notice and revision v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T01:50:14.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a government funding/operating status notice and updated the revision metadata from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-03T23:53:42.000Z thumbnail image

Stay in the know with updates to Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.